Consumer diagnostics platform company Sapphiros has signed a Covid-19 test distribution agreement with Cencora, which was formerly known as AmerisourceBergen Corporation.

Under the deal, Cencora will be responsible for distributing the Sapphiros’s GoToKnow Covid-19 Antigen Rapid Tests to pharmacies in the US.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Sapphiros expects the strategic partnership to improve accessibility and convenience for patients looking to purchase reliable Covid-19 testing solutions.

Authorised by the US Food and Drug Administration only for the detection of proteins from SARS-CoV-2, the GoToKnow rapid antigen test is developed to allow users to take tests at home.

It provides results in 15 minutes for the identification of the SARS-CoV-2 nucleocapsid protein antigen.

During the acute infection phase, this antigen is generally detectable in anterior nasal swab specimens.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Cencora will also have access to Sapphiros’s future technologies, including additional rapid lateral flow tests for diseases beyond Covid-19, a fully disposable, low-cost multiplexed molecular diagnostics platform, and the Satio blood collection patch planned to be launched early next year.

Sapphiros CEO Mark Gladwell said: “This is a significant milestone for our company and further validates Sapphiros’s unique and transformational technologies.

“We are honoured to partner with Cencora to bring this product as well as future innovative product offerings directly to patients across the US enabling the consumer to directly access their diagnostic results and manage their health.”

Backed by KKR and Neoenta, Sapphiros has a portfolio of capabilities and technologies such as novel sample collection, next-generation diagnostics, computational biology, and printed electronics.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact